carbostyril has been researched along with Infarction, Middle Cerebral Artery in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barone, FC; Hu, E; Lepore, J; Li, J; Poon, C; Qin, P; Rivera, K; Rosenbaum, DM; Willette, RN; Zhou, J; Zhuang, J | 1 |
| Kabra, DG; Kaul, CL; Sharma, SS; Thiyagarajan, M | 1 |
2 other study(ies) available for carbostyril and Infarction, Middle Cerebral Artery
| Article | Year |
|---|---|
The prolyl 4-hydroxylase inhibitor GSK360A decreases post-stroke brain injury and sensory, motor, and cognitive behavioral deficits.
Topics: Administration, Oral; Animals; Behavior, Animal; Brain; Brain Injuries; Cognition Disorders; Erythropoietin; Glycine; Hypoxia-Inducible Factor 1, alpha Subunit; Infarction, Middle Cerebral Artery; Male; Motor Activity; Organ Specificity; Prolyl Hydroxylases; Prolyl-Hydroxylase Inhibitors; Quinolones; Rats, Sprague-Dawley; RNA, Messenger; Sensation; Stroke; Vascular Endothelial Growth Factor A | 2017 |
Neuroprotective effect of 4-amino-1,8-napthalimide, a poly(ADP ribose) polymerase inhibitor in middle cerebral artery occlusion-induced focal cerebral ischemia in rat.
Topics: 1-Naphthylamine; Animals; Brain Chemistry; Brain Ischemia; Enzyme Inhibitors; In Situ Nick-End Labeling; Infarction, Middle Cerebral Artery; Male; NAD; Naphthalimides; Neuroprotective Agents; Poly(ADP-ribose) Polymerases; Quinolones; Rats; Rats, Sprague-Dawley; Reperfusion Injury | 2004 |